EUDA Health Holdings Revenue 2022-2023 | EUDA

EUDA Health Holdings revenue from 2022 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
EUDA Health Holdings Annual Revenue
(Millions of US $)
2022 $10
2021 $11
EUDA Health Holdings Quarterly Revenue
(Millions of US $)
2023-06-30
2023-03-31 $2
2022-12-31
2022-03-31 $3
2021-12-31
2021-10-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.045B $0.010B
EUDA Health Limited is a health technology company which operates southeast Asian digital healthcare ecosystem. The company's proprietary unified AI platform quickly assesses a patient's medical history, triages a condition, digitally connects patients with clinicians and predicts optimal treatment outcomes. Its holistic approach supports patients throughout all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions and aftercare services. EUDA Health Limited, formerly known as 8i Acquisition 2 Corp., is based in Singapore.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $39.221B 21.82
Inspire Medical Systems (INSP) United States $6.999B 0.00
IRhythm Technologies (IRTC) United States $3.463B 0.00
Axonics (AXNX) United States $3.394B 0.00
10x Genomics (TXG) United States $3.206B 0.00
Enovis (ENOV) United States $3.022B 22.96
Azenta (AZTA) United States $2.872B 234.09
Olink Holding AB (publ) (OLK) Sweden $2.869B 0.00
Hims & Hers Health (HIMS) United States $2.629B 0.00
Privia Health (PRVA) United States $2.135B 94.68
Schrodinger (SDGR) United States $1.688B 0.00
Omnicell (OMCL) United States $1.246B 30.48
Phreesia (PHR) United States $1.154B 0.00
Definitive Healthcare (DH) United States $0.793B 0.00
Standard BioTools (LAB) United States $0.685B 0.00
Fulgent Genetics (FLGT) United States $0.599B 0.00
Talkspace (TALK) United States $0.520B 0.00
Clover Health Investments (CLOV) United States $0.332B 0.00
Health Catalyst (HCAT) United States $0.328B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.323B 0.00
Pulmonx (LUNG) United States $0.281B 0.00
American Well (AMWL) United States $0.156B 0.00
P3 Health Partners (PIII) United States $0.152B 0.00
Butterfly Network (BFLY) United States $0.147B 0.00
Augmedix (AUGX) United States $0.136B 0.00
MSP Recovery (LIFW) United States $0.131B 0.00
Outset Medical (OM) United States $0.123B 0.00
TruBridge (TBRG) United States $0.115B 4.91
111 (YI) China $0.084B 0.00
SHL Telemedicine (SHLT) Israel $0.077B 0.00
Future Health ESG (FHLT) United States $0.070B 0.00
HeartBeam (BEAT) United States $0.052B 0.00
Zepp Health (ZEPP) China $0.052B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.031B 0.00
Movano (MOVE) United States $0.027B 0.00
Cue Health (HLTH) United States $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.022B 0.00
Streamline Health Solutions (STRM) United States $0.020B 0.00
Akili (AKLI) United States $0.019B 0.00
Strata Skin Sciences (SSKN) United States $0.019B 0.00
CareCloud (CCLD) United States $0.017B 0.00
ETAO (ETAO) United States $0.015B 0.00
Centogene (CNTG) Germany $0.013B 0.00
Biotricity (BTCY) United States $0.012B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.007B 0.00
Syra Health (SYRA) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00